Back to MAI Capital Management MAI Capital Management

TRVITRVI

Showing 8 of 18 quarters

Position history for MAI Capital ManagementMAI Capital Management's holdings in TREVI THERAPEUTICS INC

Yes. MAI Capital Management holds 56,130 shares of TRVI (Trevi Therapeutics), worth $1M, as of its Q2 2026 13F filing. It reduced the position by 8,995 shares (-13.8%) from Q1 2026. MAI Capital Management has held TRVI since Q1 2022, across 18 quarterly 13F filings.

Current Value

$1M

Current Shares

56,130

Total Value Change

-$3.4M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
56,130
-13.8%
$1M0.0%$18.65
0
2026-Q1
Decreased
65,125
-16.3%
$776,9420.0%$12.26
0
2025-Q4
Decreased
77,769
-21.0%
$973,6680.0%$12.56
0
2025-Q3
Decreased
98,492
-88.4%
$901,2020.0%$8.95
0
2025-Q2
Decreased
847,553
-38.8%
$4.6M0.0%$5.62
0
2025-Q1
Increased
1.4M
+2.1%
$8.7M0.1%$6.50
28
2024-Q4
Increased
1.4M
+2.2%
$5.6M0.0%$4.10
28
2024-Q3
Increased
1.3M
+0.7%
$4.4M0.0%$3.33
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used